155 related articles for article (PubMed ID: 38288293)
21. In vitro Inhibition of Clinical Isolates of Otitis Media Pathogens by the Probiotic Streptococcus salivarius BLIS K12.
Chen TY; Hale JDF; Tagg JR; Jain R; Voss AL; Mills N; Best EJ; Stevenson DS; Bird PA; Walls T
Probiotics Antimicrob Proteins; 2021 Jun; 13(3):734-738. PubMed ID: 33179212
[TBL] [Abstract][Full Text] [Related]
22. Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study.
Di Pierro F; Zanvit A; Nobili P; Risso P; Fornaini C
Clin Cosmet Investig Dent; 2015; 7():107-13. PubMed ID: 26491371
[TBL] [Abstract][Full Text] [Related]
23. Safety assessment of
Hale JDF; Jain R; Wescombe PA; Burton JP; Simon RR; Tagg JR
Benef Microbes; 2022 Feb; 13(1):47-60. PubMed ID: 35098909
[TBL] [Abstract][Full Text] [Related]
24. Investigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cells.
Manning J; Dunne EM; Wescombe PA; Hale JD; Mulholland EK; Tagg JR; Robins-Browne RM; Satzke C
BMC Microbiol; 2016 Sep; 16(1):225. PubMed ID: 27681377
[TBL] [Abstract][Full Text] [Related]
25. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.
Zupancic K; Kriksic V; Kovacevic I; Kovacevic D
Probiotics Antimicrob Proteins; 2017 Jun; 9(2):102-110. PubMed ID: 28236205
[TBL] [Abstract][Full Text] [Related]
26. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.
Burton JP; Chilcott CN; Moore CJ; Speiser G; Tagg JR
J Appl Microbiol; 2006 Apr; 100(4):754-64. PubMed ID: 16553730
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA.
Ogawa A; Furukawa S; Fujita S; Mitobe J; Kawarai T; Narisawa N; Sekizuka T; Kuroda M; Ochiai K; Ogihara H; Kosono S; Yoneda S; Watanabe H; Morinaga Y; Uematsu H; Senpuku H
Appl Environ Microbiol; 2011 Mar; 77(5):1572-80. PubMed ID: 21239559
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive role of Q10 with
Khodaii Z; Mardi S; Mardi P; Natanzi MM
Front Cell Infect Microbiol; 2023; 13():1053230. PubMed ID: 37187472
[TBL] [Abstract][Full Text] [Related]
29. Antibacterial Activity of a Fractionated
Di Pierro F; Sagheddu V; Galletti S; Forti M; Elli M; Bertuccioli A; Gaeta S
Front Microbiol; 2021; 12():686942. PubMed ID: 34220777
[TBL] [Abstract][Full Text] [Related]
30. Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12.
Burton JP; Chilcott CN; Wescombe PA; Tagg JR
Probiotics Antimicrob Proteins; 2010 Oct; 2(3):135-44. PubMed ID: 26781236
[TBL] [Abstract][Full Text] [Related]
31. Interferon Gamma Response in Human Saliva Following Exposure to the Oral Probiotic Streptococcus salivarius BLIS K12.
Laws GA; Harold LK; Tagg JR; Hale JDF
Probiotics Antimicrob Proteins; 2024 Feb; 16(1):93-98. PubMed ID: 36477439
[TBL] [Abstract][Full Text] [Related]
32. Genome sequence of the bacteriocin-producing oral probiotic Streptococcus salivarius strain M18.
Heng NC; Haji-Ishak NS; Kalyan A; Wong AY; Lovric M; Bridson JM; Artamonova J; Stanton JA; Wescombe PA; Burton JP; Cullinan MP; Tagg JR
J Bacteriol; 2011 Nov; 193(22):6402-3. PubMed ID: 22038965
[TBL] [Abstract][Full Text] [Related]
33. Effect of Bacteriocin-Like Inhibitory Substance (BLIS) from
Kim NN; Kim BS; Lee HB; An S; Kim D; Kang SS
Food Sci Anim Resour; 2022 Nov; 42(6):1020-1030. PubMed ID: 36415579
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial effects of herbal extracts on Streptococcus mutans and normal oral streptococci.
Lee SH
J Microbiol; 2013 Aug; 51(4):484-9. PubMed ID: 23990300
[TBL] [Abstract][Full Text] [Related]
35. Exploiting the Acidic Extracellular pH: Evaluation of Streptococcus salivarius M18 Postbiotics to Target Cancer Cells.
Karaçam S; Tunçer S
Probiotics Antimicrob Proteins; 2022 Dec; 14(6):995-1011. PubMed ID: 34080175
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo anti-microbial activity evaluation of inactivated cells of Lactobacillus salivarius CECT 5713 against Streptococcus mutans.
Sañudo AI; Luque R; Díaz-Ropero MP; Fonollá J; Bañuelos Ó
Arch Oral Biol; 2017 Dec; 84():58-63. PubMed ID: 28950179
[TBL] [Abstract][Full Text] [Related]
37. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
Tagg JR
Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154
[TBL] [Abstract][Full Text] [Related]
38. The potential of Streptococcus salivarius oral films in the management of dental caries: An inkjet printing approach.
Dodoo CC; Stapleton P; Basit AW; Gaisford S
Int J Pharm; 2020 Dec; 591():119962. PubMed ID: 33049357
[TBL] [Abstract][Full Text] [Related]
39. Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12.
Laws GL; Hale JDF; Kemp RA
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1521-1529. PubMed ID: 34282568
[TBL] [Abstract][Full Text] [Related]
40. Salivaricin E and abundant dextranase activity may contribute to the anti-cariogenic potential of the probiotic candidate Streptococcus salivarius JH.
Walker GV; Heng NCK; Carne A; Tagg JR; Wescombe PA
Microbiology (Reading); 2016 Mar; 162(3):476-486. PubMed ID: 26744310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
